XenTech SAS
PrivateLast Round
Seed
Oct 31, 2008
Total Funding Raised
$760,000
Momentum
Top 25%
of companies Caplight tracks
Company Overview
XenTech SAS is a biotechnology company that provides preclinical research services and patient-derived xenograft (PDX) models for oncology drug development.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
XenTech SAS Comparables
Compare XenTech SAS with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Experimental Pharmacology & Oncology Berlin-Buch GmbH | 89% | |
| Certis Oncology Solutions | 85% | |
| Xenopat | 83% |
XenTech SAS Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Oct 31, 2008 |
Key People
Founding team and executive leadership
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 27, 2026
Monthly visitors grew 91% MoM, reaching 2.1K.
- Mar 3, 2026
Monthly visitors grew 39% MoM, reaching 1.7K.
XenTech SAS Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about XenTech SAS's valuation, stock price, and market status.
Is XenTech SAS a public or private company?
XenTech SAS is a private company.
What is the current stock price of XenTech SAS?
XenTech SAS is a private company with no public stock price. No recent secondary market data is available.
How much is XenTech SAS worth (valuation)?
Valuation information for XenTech SAS is not publicly available.
Can I buy XenTech SAS stock?
XenTech SAS shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was XenTech SAS's last funding round?
XenTech SAS's most recent funding round was Seed on October 31, 2008.
Who are the main investors in XenTech SAS?
Investor information for XenTech SAS is not publicly disclosed.
Will XenTech SAS IPO soon?
No public IPO plans have been announced for XenTech SAS.
How can I track XenTech SAS secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor XenTech SAS's secondary market activity and sign up for updates.